249 related articles for article (PubMed ID: 11050161)
1. Amplification of dopaminergic signaling by a positive feedback loop.
Nishi A; Bibb JA; Snyder GL; Higashi H; Nairn AC; Greengard P
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12840-5. PubMed ID: 11050161
[TBL] [Abstract][Full Text] [Related]
2. Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A.
Nishi A; Bibb JA; Matsuyama S; Hamada M; Higashi H; Nairn AC; Greengard P
J Neurochem; 2002 May; 81(4):832-41. PubMed ID: 12065642
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.
Bibb JA; Snyder GL; Nishi A; Yan Z; Meijer L; Fienberg AA; Tsai LH; Kwon YT; Girault JA; Czernik AJ; Huganir RL; Hemmings HC; Nairn AC; Greengard P
Nature; 1999 Dec; 402(6762):669-71. PubMed ID: 10604473
[TBL] [Abstract][Full Text] [Related]
4. Regulation of spinophilin Ser94 phosphorylation in neostriatal neurons involves both DARPP-32-dependent and independent pathways.
Uematsu K; Futter M; Hsieh-Wilson LC; Higashi H; Maeda H; Nairn AC; Greengard P; Nishi A
J Neurochem; 2005 Dec; 95(6):1642-52. PubMed ID: 16300646
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors.
Svenningsson P; Lindskog M; Ledent C; Parmentier M; Greengard P; Fredholm BB; Fisone G
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1856-60. PubMed ID: 10677546
[TBL] [Abstract][Full Text] [Related]
6. Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling.
Nishi A; Liu F; Matsuyama S; Hamada M; Higashi H; Nairn AC; Greengard P
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1322-7. PubMed ID: 12538871
[TBL] [Abstract][Full Text] [Related]
7. D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade.
Flores-Hernandez J; Hernandez S; Snyder GL; Yan Z; Fienberg AA; Moss SJ; Greengard P; Surmeier DJ
J Neurophysiol; 2000 May; 83(5):2996-3004. PubMed ID: 10805695
[TBL] [Abstract][Full Text] [Related]
8. Glutamate Counteracts Dopamine/PKA Signaling via Dephosphorylation of DARPP-32 Ser-97 and Alteration of Its Cytonuclear Distribution.
Nishi A; Matamales M; Musante V; Valjent E; Kuroiwa M; Kitahara Y; Rebholz H; Greengard P; Girault JA; Nairn AC
J Biol Chem; 2017 Jan; 292(4):1462-1476. PubMed ID: 27998980
[TBL] [Abstract][Full Text] [Related]
9. Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum.
Chergui K; Svenningsson P; Greengard P
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2191-6. PubMed ID: 14769920
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors.
Liu F; Ma XH; Ule J; Bibb JA; Nishi A; DeMaggio AJ; Yan Z; Nairn AC; Greengard P
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11062-8. PubMed ID: 11572969
[TBL] [Abstract][Full Text] [Related]
11. A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor.
Snyder GL; Fienberg AA; Huganir RL; Greengard P
J Neurosci; 1998 Dec; 18(24):10297-303. PubMed ID: 9852567
[TBL] [Abstract][Full Text] [Related]
12. Identification of tyrosine hydroxylase as a physiological substrate for Cdk5.
Kansy JW; Daubner SC; Nishi A; Sotogaku N; Lloyd MD; Nguyen C; Lu L; Haycock JW; Hope BT; Fitzpatrick PF; Bibb JA
J Neurochem; 2004 Oct; 91(2):374-84. PubMed ID: 15447670
[TBL] [Abstract][Full Text] [Related]
13. Dopamine- and cAMP-regulated phosphoprotein DARPP-32: phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurin.
Desdouits F; Siciliano JC; Greengard P; Girault JA
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2682-5. PubMed ID: 7708705
[TBL] [Abstract][Full Text] [Related]
14. Neurotensin regulates DARPP-32 thr34 phosphorylation in neostriatal neurons by activation of dopamine D1-type receptors.
Matsuyama S; Higashi H; Maeda H; Greengard P; Nishi A
J Neurochem; 2002 Apr; 81(2):325-34. PubMed ID: 12064480
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons.
Hamada M; Higashi H; Nairn AC; Greengard P; Nishi A
J Neurochem; 2004 Sep; 90(5):1094-103. PubMed ID: 15312165
[TBL] [Abstract][Full Text] [Related]
16. Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.
Hara M; Fukui R; Hieda E; Kuroiwa M; Bateup HS; Kano T; Greengard P; Nishi A
J Neurochem; 2010 May; 113(4):1046-59. PubMed ID: 20236221
[TBL] [Abstract][Full Text] [Related]
17. Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo.
Snyder GL; Allen PB; Fienberg AA; Valle CG; Huganir RL; Nairn AC; Greengard P
J Neurosci; 2000 Jun; 20(12):4480-8. PubMed ID: 10844017
[TBL] [Abstract][Full Text] [Related]
18. Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades.
Nishi A; Watanabe Y; Higashi H; Tanaka M; Nairn AC; Greengard P
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1199-204. PubMed ID: 15657149
[TBL] [Abstract][Full Text] [Related]
19. Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice.
Fukui R; Svenningsson P; Matsuishi T; Higashi H; Nairn AC; Greengard P; Nishi A
J Neurochem; 2003 Dec; 87(6):1391-401. PubMed ID: 14713295
[TBL] [Abstract][Full Text] [Related]
20. Role of calcineurin and protein phosphatase-2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons.
Nishi A; Snyder GL; Nairn AC; Greengard P
J Neurochem; 1999 May; 72(5):2015-21. PubMed ID: 10217279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
